nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion
|
Jiang, Wenlei |
|
2015 |
17 |
4 |
p. 891-901 |
artikel |
2 |
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference
|
Yu, Lawrence X. |
|
2015 |
17 |
4 |
p. 1011-1018 |
artikel |
3 |
Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection
|
Sadekar, S. |
|
2015 |
17 |
4 |
p. 828-836 |
artikel |
4 |
Anti-repulsive Guidance Molecule C (RGMc) Antibodies Increases Serum Iron in Rats and Cynomolgus Monkeys by Hepcidin Downregulation
|
Böser, Preethne |
|
2015 |
17 |
4 |
p. 930-938 |
artikel |
5 |
Applications of In Vitro–In Vivo Correlations in Generic Drug Development: Case Studies
|
Kaur, Paramjeet |
|
2015 |
17 |
4 |
p. 1035-1039 |
artikel |
6 |
Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls
|
Papich, Mark G. |
|
2015 |
17 |
4 |
p. 948-964 |
artikel |
7 |
A Systematic Analysis of the Sensitivity of Plasma Pharmacokinetics to Detect Differences in the Pulmonary Performance of Inhaled Fluticasone Propionate Products Using a Model-Based Simulation Approach
|
Weber, Benjamin |
|
2015 |
17 |
4 |
p. 999-1010 |
artikel |
8 |
Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation
|
Marcelletti, John F. |
|
2015 |
17 |
4 |
p. 939-947 |
artikel |
9 |
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay
|
Ni, Yan G. |
|
2015 |
17 |
4 |
p. 976-987 |
artikel |
10 |
Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates
|
Polak, Sebastian |
|
2015 |
17 |
4 |
p. 1025-1032 |
artikel |
11 |
Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat
|
Chadha, Gurkishan S. |
|
2015 |
17 |
4 |
p. 965-975 |
artikel |
12 |
Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models
|
Mathias, Neil |
|
2015 |
17 |
4 |
p. 988-998 |
artikel |
13 |
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
|
Meredith, M. Elizabeth |
|
2015 |
17 |
4 |
p. 780-787 |
artikel |
14 |
In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers
|
Horhota, Stephen T. |
|
2015 |
17 |
4 |
p. 871-880 |
artikel |
15 |
In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches
|
Forbes, Ben |
|
2015 |
17 |
4 |
p. 837-852 |
artikel |
16 |
Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs
|
Kleppe, Mary S. |
|
2015 |
17 |
4 |
p. 902-917 |
artikel |
17 |
Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9
|
Budha, Nageshwar R. |
|
2015 |
17 |
4 |
p. 881-890 |
artikel |
18 |
Molecular Imaging of Membrane Transporters’ Activity in Cancer: a Picture is Worth a Thousand Tubes
|
Mann, Aniv |
|
2015 |
17 |
4 |
p. 788-801 |
artikel |
19 |
Multidrug Resistance Proteins (MRPs) and Cancer Therapy
|
Zhang, Yun-Kai |
|
2015 |
17 |
4 |
p. 802-812 |
artikel |
20 |
On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced Designs
|
Morales-Alcelay, S. |
|
2015 |
17 |
4 |
p. 1033-1034 |
artikel |
21 |
Peptide Developability at the Discovery-to-Development Interface—Current State and Future Opportunities
|
Bak, Annette |
|
2015 |
17 |
4 |
p. 777-779 |
artikel |
22 |
Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs
|
Borghardt, Jens Markus |
|
2015 |
17 |
4 |
p. 853-870 |
artikel |
23 |
Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer
|
Ortiz, Raúl |
|
2015 |
17 |
4 |
p. 918-929 |
artikel |
24 |
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases
|
Talekar, Meghna |
|
2015 |
17 |
4 |
p. 813-827 |
artikel |
25 |
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment
|
Kelley, Marian |
|
2015 |
17 |
4 |
p. 1019-1024 |
artikel |